Compare American Well Corp (AMWL) vs The Vita Coco Company Inc (COCO) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
American Well Corp vs The Vita Coco Company Inc — how do they compare? American Well Corp trades at $9.61 (market cap $165.58M), while The Vita Coco Company Inc trades at $71.23 (market cap $4.08B). The key difference: The Vita Coco Company Inc is far larger — about 24.6× American Well Corp's market cap, and American Well Corp is trading nearer its 52-week high, The Vita Coco Company Inc nearer its low. Which is the better fit depends on your goals.
| AMWL | COCO | |
|---|---|---|
Market Cap | $165.58M | $4.08B |
Sector | Health | Technology |
52-Week High | $9.91 | $84.02 |
52-Week Low | $3.78 | $32.30 |
Enterprise Value | -$9.66M | $3.89B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMWL trades at $9.91, up 8.66% today, with bullish technical signals and positive momentum. The company shows improving financial trends with declining losses and strong gross margins of 52.9%, though it remains unprofitable with a -37.02% net margin. Recent news highlights Amazon's appointment of Amwell's co-founder to lead its healthcare unit, signaling industry validation.
While AMWL shows operational improvement and attractive valuation multiples (P/S 0.68, P/B 0.73), the stock faces headwinds from persistent losses and negative cash flow. Analyst consensus is cautious with a $7.25 price target below current levels, suggesting limited near-term upside despite recent positive momentum.
Vita Coco (COCO) trades at $71.40, up 0.21% with a bullish technical signal supported by moving averages. The company demonstrates strong fundamentals with 37.4% gross margins and 26.32% ROE, though valuation metrics appear elevated with a P/E of 51.74. Recent Q1 2026 earnings beat expectations by 47%, while analysts maintain a 60% buy rating consensus with a $78 price target. The company is scheduled to report Q2 2026 results on July 23, 2026.
COCO presents growth potential driven by market leadership in coconut water and projected revenue expansion to $659M in 2026. However, premium valuation and competitive pressures in the beverage sector warrant caution. The stock's near-term catalyst will be Q2 earnings performance against the $0.56 EPS expectation, with technical support at $69 and resistance at $73.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About American Well Corp
American Well Corp is a telehealth company enabling digital delivery of care for its customers. Its platform, Amwell, digital care delivery solution that equips health systems, health plans, government, and innovator clients with the tools to enable new models of care for their patients and members enabling care delivery across the full healthcare continuum - from primary and urgent care in the home to high acuity specialty consults, such as telestroke and telepsychiatry, in the hospital. It provides both on-demand and scheduled consultations. Its Health Plan Programs include Virtual Primary Care, Musculoskeletal Care, Dermatology Care, and Chronic Care among others and its Health System Modules include Acute Behavioral Health, ED Triage, Pediatrics and Telestroke among others.
Read more on AMWL →About The Vita Coco Company Inc
The Vita Coco Company is a leading functional beverage brand specializing in coconut water. Its portfolio includes its flagship Vita Coco brand, clean energy drinks, and sustainable enhanced water products.
Read more on COCO →
